Natera promotes Solomon Moshkevich to CEO

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 06 Nov, 17:46 UTC

The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for the role.